References
- ZamboniWCConcept and clinical evaluation of carrier-mediated anticancer agentsOncologist20081324826018378535
- HanahanDWeinbergRAThe hallmarks of cancerCell2000100577010647931
- ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev2008601615162618840489
- PuriALoomisKSmithBLipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicCrit Rev Ther Drug Carrier Syst20092652358020402623
- ImmordinoMLDosioFCattelLStealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialInt J Nanomedicine2006129731517717971
- McNeilSENanoparticle therapeutics: a personal perspectiveWiley Interdiscip Rev Nanomed Nanobiotechnol2009126427120049796
- BurgerKNStaffhorstRWde VijlderHCNanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicityNat Med20028818411786911
- YubaEHaradaASakanishiYKonoKCarboxylated hyperbranched poly(glycidol)s for preparation of pH-sensitive liposomesJ Control Release2011149728020206654
- ElBayoumiTATorchilinVPTumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibodyClin Cancer Res2009151973198019276264
- SaadMGarbuzenkoOBMinkoTCo-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancerNanomedicine (Lond)2008376177619025451
- GargATisdaleAWHaidariEKokkoliETargeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptideInt J Pharm20093661–220121018835580
- StrijkersGJKluzaEVan TilborgGAParamagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesisAngiogenesis20101316117320390447
- SinghSVHuXSrivastavaSKMechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcuminCarcinogenesis199819135713609744529
- ChoudhuriTPalSDasTSaGCurcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent mannerJ Biol Chem2005280200592006815738001
- ChengALHsuCHLinJKPhase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesionsAnticancer Res2001212895290011712783
- ThangapazhamRLPuriATeleSBlumenthalRMaheshwariRKEvaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cellsInt J Oncol2008321119112318425340
- LiLBraitehFSKurzrockRLiposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesisCancer20051041322133116092118
- HanHDLeeAHwangTEnhanced circulation time and antitumor activity of doxorubicin by comb like polymer-incorporated liposomesJ Control Release200712016116817524514
- LavermanPBrouwersAHDamsETPreclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid doseJ Pharmacol Exp Ther2000293996100110869403
- LavermanPCarstensMGBoermanOCFactors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injectionJ Pharmacol Exp Ther200129860761211454922
- IshidaTWangXShimizuTNawataKKiwadaHPEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent mannerJ Control Release2007122334935517610982
- OerlemansCBultWBosMStormGNijsenJFHenninkWEPolymeric micelles in anticancer therapy: targeting, imaging and triggered releasePharm Res2010272569258920725771
- TorchilinVPLukyanovANGaoZPapahadjopoulos-SternbergBImmunomicelles: targeted pharmaceutical carriers for poorly soluble drugsProc Natl Acad Sci U S A20031006039604412716967
- MusacchioTLaquintanaVLatrofaATrapaniGTorchilinVPPEG-PE micelles loaded with paclitaxel and surface-modified by a PBR-ligand: synergistic anticancer effectMol Pharm2009646847919718800
- VauthierCLabarreDPonchelGDesign aspects of poly (alkylcyanoacrylate) nanoparticles for drug deliveryJ Drug Target20071564166318041633
- AmbruosiAKhalanskyASYamamotoHGelperinaSEBegleyDJKreuterJBiodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing ratsJ Drug Target2006149710516608736
- AmbruosiAGelperinaSKhalanskyATanskiSTheisenAKreuterJInfluence of surfactants, polymer and doxorubicin loading on the antitumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma modelJ Microencapsul20062358259216980278
- BriggerIMorizetJAubertGPoly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targetingJ Pharmacol Exp Ther200230392893612438511
- BriggerIMorizetJLaudaniLNegative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor modelJ Control Release2004100294015491808
- DuanJZhangYHanSSynthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticlesInt J Pharm201040021122020813175
- MulikRSMonkkonenJJuvonenROMahadikKRParadkarARApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture modelMol Pharm2010781582520230014
- BriggerIChaminadePMarsaudVTamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulationInt J Pharm2001214374211282234
- StellaBArpiccoSRoccoFEncapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsulesInt J Pharm20073441–2717717651931
- ToubNBertrandJRTamaddonAEfficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcomaPharm Res200623589290016715379
- YousefiAEsmaeiliFRshimianSAtyabiFDinarvandRPreparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxelSci Pharm200977453464
- SharmaRYasirMBhaskarSAsifMFormulation and evaluation of paclitaxel loaded PSA-PEG nanoparticleJ App Pharm Sci201119698
- NobsLBucheggerFGurnyRAllmannEBiodegradable nanoparticles for direct or two-step tumor immunotargetingBioconjug Chem20061713914516417262
- ParkJWHongKKirpotinDBAnti-HER2 immunoliposomes: enhanced efficacy attributable to targeted deliveryClin Cancer Res200281172118111948130
- SunBRanganathanBFengSSMultifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancerBiomaterials20082947529486
- DayESBickfordLRSlaterJHRiggallNSDrezekRAWestJLAntibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancerInt J Nanomedicine2010544545420957166
- ShahzadMMMangalaLSHanHDTargeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticlesNeoplasia20111330931921472135
- WuPHeXWangKImaging breast cancer cells and tissues using peptide-labeled fluorescent silica nanoparticlesJ Nanosci Nanotechnol200882483248718572669
- HanHDMangalaLSLeeJWTargeted gene silencing using RGD-labeled chitosan nanoparticlesClin Cancer Res2010163910392220538762
- FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A20061036315632016606824
- SalazarMDRatnamMThe folate receptor: what does it promise in tissue- targeted therapeuticsCancer Metastasis Rev20072614115217333345
- KamenBASmithAKA review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitroAdv Drug Deliv Rev2004561085109715094208
- AntonyACThe biological chemistry of folate receptorsBlood199279280728201586732
- MathiasCJHubersDLowPSGreenMASynthesis of [(99 m) Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceuticalBioconjug Chem20001125325710725102
- UlbrichKMichaelisMRothweilerFInteraction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cellsInt J Pharm201140612813421185364
- RossinRPanDQiK64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluationJ Nucl Med2005461210121816000291
- YangSJLinFHTsaiHMAlginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasmsBiomaterials2011322174218221163518
- LeeRJLowPSFolate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitroBiochim Biophys Acta199512331341447865538
- PanXQWangHLeeRJAntitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft modelPharm Res20032041742212669962
- ChoiHChoiSRZhouRKungHFChenIWIron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted deliveryAcad Radiol200411996100415350580
- BackerMVGaynutdinovTIPatelVVascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculatureMol Cancer Ther20051423142916170035
- LiLWartchowCADanthiSNA novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticlesInt J Radiat Oncol Biol Phys2004581215122715001266
- HoodJDBednarskiMFraustoRTumor regression by targeted gene delivery to the neovasculatureScience20022962404240712089446
- GoskSMoosTGottsteinCBendasGVCAM-1 directed immunoliposomes selectively target tumor vasculature in vivoBiochim Biophys Acta200885486318211818
- KirpotinDBDrummondDCShaoYAntibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsCancer Res2006666732674016818648
- PunSHTackFBellocqNCTargeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particlesCancer Biol Ther2004364165015136766
- ShmeedaHMakLTzemachDAstrahanPTarshishMGabizonAIntracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptorsMol Cancer Ther2006581882416648551
- JainRKNormalization of tumor vasculature: an emerging concept in antiangiogenic therapyScience2005307586215637262
- IzumiYXuLTomasoEFukumuraDJainRKTumor biology: Herceptin acts as an anti-angiogenic cocktailNature200241627928011907566
- GazeauFLévyMWilhelmCOptimizing magnetic nanoparticle design for nanothermotherapyNanomed20083831844
- KrishnanSDiagaradjanePChoSNanoparticle-mediated thermal therapy: Evolving strategies for prostate cancer therapyInt J Hyperthermia20112677578920858069
- DeNardoGLDeNardoSJUpdate: turning the heat on cancerCancer Biother Radiopharm20082367168020443694
- SantoshamRDevBPriyadarshiniPHow I do it: Radiofrequency ablationIndian J Radiol Imaging200818166170
- MerkleEMGoldbergSNBollDTEffects of superparamagnetic iron oxide on radiofrequency-induced temperature distribution: in vitro measurements in polyacrylamide phantoms and in vivo results in a rabbit liver modelRadiology199921245946610429704
- McBainSCYiuHHDobsonJMagnetic nanoparticles for gene and drug deliveryInt J Nanomedicine2008316918018686777
- ThiesenBJordanAClinical applications of magnetic nanoparticles for hyperthermiaInt J Hyperthermia20082446747418608593
- RocaAGCostoRRebolledoAFProgress in the preparation of magnetic nanoparticles for applications in biomedicineJ Phys D: Appl Phys200942224002224012
- IvkovRDeNardoSJDaumWApplication of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancerClin Cancer Res20051170937103
- Maier-HauffKUlrichFNestlerDEfficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJ Neurooncol201110331732420845061
- OcchipintiEVerderioPNatalelloAInvestigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticlesNanoscale2011338739020877896
- NatarajanAXiongCYGruettnerCDeNardoGLDeNardoSJDevelopment of multivalent radioimmunonanoparticles for cancer imaging and therapyCancer Biother Radiopharm200823829118298332